Search research articles
Contact Us
Filters
Showing results (231-240 of 627) with videos related to
Page
of 63
Sort By:
Urology
|
June 15, 1999
Male urethral carcinoma: analysis of treatment outcome
G Dalbagni, Z F Zhang, L Lacombe, et al.
Molecular and Cellular Biology
|
June 21, 2001
DNA recognition by the herpes simplex virus transactivator VP16: a novel DNA-binding structure
R Babb, C C Huang, D J Aufiero, et al.
Science (New York, N.Y.)
|
January 30, 1970
Determination of manganese-53 by neutron activation and other miscellaneous studies on lunar dust
W Herr, U Herpers, B Hess, et al.
Cell
|
July 16, 1993
The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor protein
A C Wilson, K LaMarco, M G Peterson, et al.
The Journal of Urology
|
January 10, 2004
Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm
S Machele Donat, Amanda North, Guido Dalbagni, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 16, 2005
D-optimal experimental designs to test for departure from additivity in a fixed-ratio mixture ray
Todd Coffey, Chris Gennings, Jane Ellen Simmons, et al.
British Journal of Urology
|
January 12, 1999
Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy
G Dalbagni, Z F Zhang, L Lacombe, et al.
The Journal of Urology
|
October 9, 2003
Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer
S Machele Donat, Sharon Bayuga, Harry W Herr, et al.
Urology
|
July 1, 1991
Perirenal lipoma versus renal cell carcinoma
J H Mydlo, N Shore, V Reuter, et al.
National Cancer Institute Monograph
|
December 1, 1978
Poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder
H W Herr, N Kemeny, A Yagoda, et al.
Page
of 63
Search research articles
Search
Showing results (231-240 of 627) with videos related to
Sort By:
Page
of 63
Urology
|
June 15, 1999
Male urethral carcinoma: analysis of treatment outcome
G Dalbagni, Z F Zhang, L Lacombe, et al.
Molecular and Cellular Biology
|
June 21, 2001
DNA recognition by the herpes simplex virus transactivator VP16: a novel DNA-binding structure
R Babb, C C Huang, D J Aufiero, et al.
Science (New York, N.Y.)
|
January 30, 1970
Determination of manganese-53 by neutron activation and other miscellaneous studies on lunar dust
W Herr, U Herpers, B Hess, et al.
Cell
|
July 16, 1993
The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor protein
A C Wilson, K LaMarco, M G Peterson, et al.
The Journal of Urology
|
January 10, 2004
Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm
S Machele Donat, Amanda North, Guido Dalbagni, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 16, 2005
D-optimal experimental designs to test for departure from additivity in a fixed-ratio mixture ray
Todd Coffey, Chris Gennings, Jane Ellen Simmons, et al.
British Journal of Urology
|
January 12, 1999
Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy
G Dalbagni, Z F Zhang, L Lacombe, et al.
The Journal of Urology
|
October 9, 2003
Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer
S Machele Donat, Sharon Bayuga, Harry W Herr, et al.
Urology
|
July 1, 1991
Perirenal lipoma versus renal cell carcinoma
J H Mydlo, N Shore, V Reuter, et al.
National Cancer Institute Monograph
|
December 1, 1978
Poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder
H W Herr, N Kemeny, A Yagoda, et al.
Page
of 63